{"id":"https://openalex.org/W19818330","doi":"https://doi.org/10.1200/jco.2004.22.14_suppl.2565","title":"Post-vaccination CTLA-4 expression correlates inversely with survival in patients vaccinated with allogeneic melanoma cell vaccine","display_name":"Post-vaccination CTLA-4 expression correlates inversely with survival in patients vaccinated with allogeneic melanoma cell vaccine","publication_year":2004,"publication_date":"2004-07-15","ids":{"openalex":"https://openalex.org/W19818330","doi":"https://doi.org/10.1200/jco.2004.22.14_suppl.2565","mag":"19818330"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2004.22.14_suppl.2565","doi":"https://doi.org/10.1200/jco.2004.22.14_suppl.2565","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2004.22.14_suppl.2565","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5080404941","display_name":"Mark B. Faries","orcid":"https://orcid.org/0000-0003-1752-7282","observed_orcids":["https://orcid.org/0000-0003-1752-7282"]},"institutions":[{"id":"https://openalex.org/I47838141","display_name":"Saint Louis University","ror":"https://ror.org/01p7jjy08","country_code":"US","type":"education","lineage":["https://openalex.org/I47838141"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"M. B. Faries","raw_affiliation_strings":["John Wayne Cancer Institute, Santa Monica, CA; University of St. Louis, St. Louis, MO"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"John Wayne Cancer Institute, Santa Monica, CA; University of St. Louis, St. Louis, MO","institution_ids":["https://openalex.org/I47838141"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5025558951","display_name":"Eddy C. Hsueh","orcid":"https://orcid.org/0000-0002-0327-2605","observed_orcids":["https://orcid.org/0000-0002-0327-2605"]},"institutions":[{"id":"https://openalex.org/I47838141","display_name":"Saint Louis University","ror":"https://ror.org/01p7jjy08","country_code":"US","type":"education","lineage":["https://openalex.org/I47838141"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"E. C. Hsueh","raw_affiliation_strings":["John Wayne Cancer Institute, Santa Monica, CA; University of St. Louis, St. Louis, MO"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"John Wayne Cancer Institute, Santa Monica, CA; University of St. Louis, St. Louis, MO","institution_ids":["https://openalex.org/I47838141"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5014713398","display_name":"S Shu","orcid":"https://orcid.org/0009-0007-4432-9042","observed_orcids":["https://orcid.org/0009-0007-4432-9042"]},"institutions":[{"id":"https://openalex.org/I47838141","display_name":"Saint Louis University","ror":"https://ror.org/01p7jjy08","country_code":"US","type":"education","lineage":["https://openalex.org/I47838141"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"S. Shu","raw_affiliation_strings":["John Wayne Cancer Institute, Santa Monica, CA; University of St. Louis, St. Louis, MO"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"John Wayne Cancer Institute, Santa Monica, CA; University of St. Louis, St. Louis, MO","institution_ids":["https://openalex.org/I47838141"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023966621","display_name":"Estela Famatiga","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I47838141","display_name":"Saint Louis University","ror":"https://ror.org/01p7jjy08","country_code":"US","type":"education","lineage":["https://openalex.org/I47838141"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"E. Famatiga","raw_affiliation_strings":["John Wayne Cancer Institute, Santa Monica, CA; University of St. Louis, St. Louis, MO"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"John Wayne Cancer Institute, Santa Monica, CA; University of St. Louis, St. Louis, MO","institution_ids":["https://openalex.org/I47838141"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5108353019","display_name":"D L Morton","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I47838141","display_name":"Saint Louis University","ror":"https://ror.org/01p7jjy08","country_code":"US","type":"education","lineage":["https://openalex.org/I47838141"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"D. L. Morton","raw_affiliation_strings":["John Wayne Cancer Institute, Santa Monica, CA; University of St. Louis, St. Louis, MO"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"John Wayne Cancer Institute, Santa Monica, CA; University of St. Louis, St. Louis, MO","institution_ids":["https://openalex.org/I47838141"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I47838141"],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":3,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"22","issue":"14_suppl","first_page":"2565","last_page":"2565"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.7914999723434448,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.7914999723434448,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.19460000097751617,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10031","display_name":"T-cell and B-cell Immunology","score":0.008700000122189522,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/ctla-4","display_name":"CTLA-4","score":0.9800000190734863},{"id":"https://openalex.org/keywords/melanoma","display_name":"melanoma","score":0.6959999799728394},{"id":"https://openalex.org/keywords/cancer-immunotherapy","display_name":"cancer immunotherapy","score":0.6439999938011169},{"id":"https://openalex.org/keywords/t-cell-activation","display_name":"T cell activation","score":0.4959999918937683},{"id":"https://openalex.org/keywords/prognostic-factors","display_name":"prognostic factors","score":0.7929999828338623},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.7620000243186951},{"id":"https://openalex.org/keywords/ctla-4-blockade","display_name":"CTLA-4 blockade","score":0.9340000152587891}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8621028661727905},{"id":"https://openalex.org/C22070199","wikidata":"https://www.wikidata.org/wiki/Q192995","display_name":"Vaccination","level":2,"score":0.8030311465263367},{"id":"https://openalex.org/C2777863537","wikidata":"https://www.wikidata.org/wiki/Q357896","display_name":"Adjuvant","level":2,"score":0.6325023174285889},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.5572552680969238},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.5564661622047424},{"id":"https://openalex.org/C21705690","wikidata":"https://www.wikidata.org/wiki/Q2907609","display_name":"CTLA-4","level":4,"score":0.5303769111633301},{"id":"https://openalex.org/C2776090121","wikidata":"https://www.wikidata.org/wiki/Q193529","display_name":"T cell","level":3,"score":0.48637130856513977},{"id":"https://openalex.org/C553184892","wikidata":"https://www.wikidata.org/wiki/Q1141429","display_name":"Flow cytometry","level":2,"score":0.47854548692703247},{"id":"https://openalex.org/C2777658100","wikidata":"https://www.wikidata.org/wiki/Q180614","display_name":"Melanoma","level":2,"score":0.46080493927001953},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.4240705072879791},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.4136055111885071},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.32303863763809204},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.2438567578792572}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.1200/jco.2004.22.14_suppl.2565","doi":"https://doi.org/10.1200/jco.2004.22.14_suppl.2565","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2004.22.14_suppl.2565","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},{"id":"doi:10.1200/jco.2004.22.90140.2565","doi":"https://doi.org/10.1200/jco.2004.22.90140.2565","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2004.22.90140.2565","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2404598267","https://openalex.org/W2144681204","https://openalex.org/W1643557676","https://openalex.org/W2096554723","https://openalex.org/W2172083530","https://openalex.org/W2026599056","https://openalex.org/W95660081","https://openalex.org/W2400683489","https://openalex.org/W2130826299","https://openalex.org/W1906398111"],"abstract_inverted_index":{"2565":[0],"Background:":[1],"Immunologic":[2],"endpoints":[3],"are":[4],"often":[5],"utilized":[6],"in":[7,22,52,61,132,266,283],"cancer":[8],"vaccine":[9,24,234,268],"trials":[10],"as":[11],"surrogates":[12],"to":[13,141,177,280],"clinical":[14,278],"outcomes.":[15],"However":[16],"validation":[17],"of":[18,117,128,136,169,241],"these":[19],"endpoints,":[20],"particularly":[21],"adjuvant":[23,267],"trials,":[25],"is":[26,48],"not":[27,187],"yet":[28],"thoroughly":[29],"explored.":[30],"Signaling":[31],"through":[32],"CTLA-4":[33,59,121,131,173,191,208,216,242,281],"has":[34],"been":[35],"associated":[36],"with":[37,66,73,88,107,143,190,204,215,248,252,285],"a":[38,50,201,260,277],"diminished":[39],"T":[40,62,80,118,137,170,195,206,244],"cell":[41,45,77,207],"response,":[42],"and":[43,70,105,113,148,179],"this":[44],"surface":[46],"molecule":[47],"now":[49],"target":[51],"some":[53],"melanoma":[54,76,90,286],"immunotherapy":[55],"trials.":[56,269],"We":[57],"examined":[58],"expression":[60,192,209],"cells":[63,81,91,102,119,138,171,196,245],"upon":[64],"stimulation":[65,247],"autologous":[67,89,249],"tumor":[68,250],"before":[69,147],"after":[71,149,246],"vaccination":[72,178],"an":[74],"allogeneic":[75],"vaccine.":[78],"Methods:":[79],"isolated":[82],"from":[83,93,153],"cryopreserved":[84],"PBMC":[85],"were":[86,103,156],"co-cultured":[87],"(isolated":[92],"surgically":[94],"resected":[95],"metastases)":[96],"for":[97,111,161,213,224,236],"3":[98],"days.":[99],"After":[100],"culture,":[101],"harvested":[104],"stained":[106],"fluorochrome":[108],"labeled":[109],"antibodies":[110],"CD3":[112],"CTLA-4.":[114],"The":[115],"percentage":[116],"expressing":[120,130,172,243],"was":[122,139,164,174,200,218,227],"determined":[123],"using":[124],"flow":[125],"cytometry.":[126],"Survival":[127,185],"patients":[129,155,214,232],"greater":[133],"than":[134,145],"1%":[135,146],"compared":[140],"those":[142,225],"less":[144],"vaccination.":[150],"Results:":[151],"Lymphocytes":[152],"15":[154],"examined.":[157],"Median":[158],"overall":[159,254],"survival":[160,212,223],"the":[162],"group":[163],"42.6":[165],"months.":[166,229],"Mean":[167],"percent":[168],"1.01%":[175],"prior":[176],"0.78%":[180],"2\u20133":[181],"months":[182],"post-vaccination":[183,205],"(p=0.11).":[184],"did":[186],"correlate":[188],"significantly":[189],"by":[193],"pre-vaccination":[194],"(p=0.51),":[197],"but":[198],"there":[199,274],"strong":[202],"correlation":[203],"(Wilcoxon":[210],"p=0.04).Median":[211],">1%post-vaccination":[217],"15.9":[219],"months,":[220],"while":[221],"median":[222],"<1%":[226],"74":[228],"Conclusions:":[230],"In":[231],"undergoing":[233],"therapy":[235],"melanoma,":[237],"relatively":[238],"high":[239],"levels":[240],"correlates":[251],"decreased":[253],"survival.":[255],"This":[256],"measurement":[257],"may":[258,275],"be":[259,276],"prognostically":[261],"important":[262],"immunologic":[263],"surrogate":[264],"measure":[265],"It":[270],"also":[271],"suggests":[272],"that":[273],"benefit":[279],"blockade":[282],"conjunction":[284],"immunotherapy.":[287],"Author":[288],"Disclosure":[289],"Employment":[290],"or":[291,294],"Leadership":[292],"Consultant":[293],"Advisory":[295],"Stock":[296],"Ownership":[297],"Honoraria":[298],"Research":[299],"Funding":[300],"Expert":[301],"Testimony":[302],"Other":[303],"Remuneration":[304],"Cancervax":[305,307,309],"Corp.":[306,308,310]},"counts_by_year":[],"updated_date":"2026-10-12T09:40:04.860316","created_date":"2016-06-24T00:00:00"}